Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study)

International Immunopharmacology (2021) - Comments
pubmed: 33421928 doi: 10.1016/j.intimp.2020.107301 issn: 1567-5769 issn: 1878-1705

Mili Shah, Jignasha Captain, Vidyadhar Vaidya, Arvind Kulkarni, Kedar Valsangkar, Pradeep M.K. Nair, Gayatri Ganu